İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

BETÜL KAYA

DOÇENT

BİLECİK ŞEYH EDEBALİ ÜNİVERSİTESİ SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU ECZANE HİZMETLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 127
  • Proje 0
  • Kitap 0
  • Bildiri 48
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 39 Q2 28 Q3 40 Q4 8
WoS (JCR) Q1 18 Q2 43 Q3 36 Q4 16
TR Index 10 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 31
Ort. yüzdelik 72.5%
Üst %1 payı 0.0%
Üst %10 payı 25.0%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 127 yayın

Scopus (SJR)
Q1 39 Q2 28 Q3 40 Q4 8
WoS (JCR)
Q1 18 Q2 43 Q3 36 Q4 16
TR Index
10 makale

Makale listesi

  1. 2026 Benzothiazole-thiadiazole hybrids as dual α-glucosidase and aldose reductase inhibitors: Synthesis, in vitro, and In Silico studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.144995 YÖKSİS SJR Q2 JCR Q2 OpenAlex 28.2%
  2. 2025 Design, Synthesis, In Silico Absorption, Distribution, Metabolism, and Elimination and Molecular Docking Studies of Thiazole‐Based Furan Derivatives, and Their Biological Evaluation for Alzheimer Disease Therapy ChemistryOpen DOI 10.1002/open.202500305 YÖKSİS SJR Q2 JCR Q2 OpenAlex 87.9%
  3. 2025 Discovery of Hydrazine Clubbed Thiazoles as Potential Antidiabetic Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies Drug Development Research DOI 10.1002/ddr.70060 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 95.4%
  4. 2025 Design, synthesis and evaluation of thiazole derivatives as cholinesterase inhibitors and antioxidant agents Phosphorus, Sulfur, and Silicon and the Related Elements DOI 10.1080/10426507.2025.2508322 YÖKSİS SJR Q4 JCR Q3 OpenAlex üst %10 OpenAlex 94.3%
  5. 2025 Synthesis of Novel Benzofuran-Based Thiazole Hybrids and Investigation of Their Antioxidant and Anticholinesterase Activities Fabad Journal of Pharmaceutical Sciences DOI 10.55262/fabadeczacilik.1678454 YÖKSİS SJR Q3 OpenAlex 76.1%
  6. 2025 Design, Synthesis, and Molecular Docking Studies of Novel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitors for the Treatment of Alzheimer’s Disease ACS Omega DOI 10.1021/acsomega.5c01055 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 96.6%
  7. 2025 Design, Synthesis, and Molecular Docking Studies of Novel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitors for the Treatment of Alzheimer’s Disease ACS Omega DOI 10.1021/acsomega.5c01055 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 96.6%
  8. 2025 Discovery of Hydrazine Clubbed Thiazoles as Potential Antidiabetic Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies Drug Development Research DOI 10.1002/ddr.70060 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 95.4%
  9. 2025 Design, Synthesis, In Silico Absorption, Distribution, Metabolism, and Elimination and Molecular Docking Studies of Thiazole‐Based Furan Derivatives, and Their Biological Evaluation for Alzheimer Disease Therapy ChemistryOpen DOI 10.1002/open.202500305 YÖKSİS SJR Q2 JCR Q2 OpenAlex 87.9%
  10. 2025 Latest developments in small molecule analgesics: heterocyclic scaffolds I. Future medicinal chemistry DOI 10.1080/17568919.2025.2546783 YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 93.6%
  11. 2025 Latest developments in small molecule analgesics: heterocyclic scaffolds I Future Medicinal Chemistry DOI 10.1080/17568919.2025.2546783 YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 93.6%
  12. 2025 Design, synthesis and evaluation of thiazole derivatives as cholinesterase inhibitors and antioxidant agents Phosphorus, Sulfur, and Silicon and the Related Elements DOI 10.1080/10426507.2025.2508322 YÖKSİS SJR Q4 JCR Q3 OpenAlex üst %10 OpenAlex 94.3%
  13. 2025 Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α-Glucosidase for Diabetes Mellitus ACS Omega DOI 10.1021/acsomega.5c00566 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.0%
  14. 2025 Design and synthesis of new 1,3,4-thiadiazoles as antimicrobial and antibiofilm agents Zeitschrift für Naturforschung C DOI 10.1515/znc-2024-0294 YÖKSİS SJR Q3 JCR Q3 OpenAlex 69.9%
  15. 2025 Synthesis, antibacterial, anti-urease, DFT and molecular docking studies of novel bis-1,3,4-thiadiazoles Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.140134 YÖKSİS SJR Q2 JCR Q2 OpenAlex 52.2%
  16. 2025 Benzothiazole-thiadiazole hybrids as dual α-glucosidase and aldose reductase inhibitors: Synthesis, in vitro, and In Silico studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.144995 YÖKSİS SJR Q2 JCR Q2 OpenAlex 28.2%
  17. 2025 Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α-Glucosidase for Diabetes Mellitus ACS Omega DOI 10.1021/acsomega.5c00566 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.0%
  18. 2025 Synthetic strategies and biological screening of novel pyrazolines as COX inhibitors European Journal of Life Sciences DOI 10.55971/EJLS.1712793 YÖKSİS OpenAlex 10.4%
  19. 2025 Synthetic strategies and biological screening of novel pyrazolines as COX inhibitors European Journal of Life Sciences DOI 10.55971/EJLS.1712793 YÖKSİS OpenAlex 10.4%
  20. 2025 Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Benzothiazole-Based 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents Anti-Cancer Agents in Medicinal Chemistry DOI 10.2174/0118715206353584241018051852 YÖKSİS SJR Q3 JCR Q3 OpenAlex 83.2%

Akademisyenlere dön